Is Bunavail the Answer to the Opioid Drug Epidemic?

June 10 (Bloomberg) –- In today’s “Global Outlook,” BioDelivery Sciences CEO Mark Sirgo discusses the company's drug Bunavail, which is used to treat opioid depenedence. He speaks with Trish Regan on Bloomberg Television's "Street Smart." (Source: Bloomberg)
The Benefits of EMV Credit Card Chip Technology
03:46 - Ellen Richey, Visa's chief enterprise risk officer, explains the benefits of EMV credit card chip technology. She speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • ‘The Martian’: $108 Million Movie Debuts This Weekend
  • What’s Behind the Labor Market is Slow Down?
  • How GE Is Appealing to the Tech Audience